Literature DB >> 22802525

SPRED proteins provide a NF-ty link to Ras suppression.

Andrea I McClatchey1, Karen Cichowski.   

Abstract

Mutations in the SPRED1 (Sprouty-related protein with an EVH [Ena/Vasp homology] domain 1) and NF1 (neurofibromatosis 1) genes underlie clinically related human disorders. The NF1-encoded protein neurofibromin is a Ras GTPase-activating protein (GAP) and can directly limit Ras activity. Spred proteins also negatively regulate Ras signaling, but the mechanism by which they do so is not clear. In the July 1, 2012, issue of Genes & Development, Stowe and colleagues (pp. 1421-1426) present evidence that Spred1 recruits neurofibromin to the membrane, where it dampens growth factor-induced Ras activity, providing a satisfying explanation for the overlapping features of two human diseases.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22802525      PMCID: PMC3404379          DOI: 10.1101/gad.197434.112

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  32 in total

Review 1.  NF1 tumor suppressor gene function: narrowing the GAP.

Authors:  K Cichowski; T Jacks
Journal:  Cell       Date:  2001-02-23       Impact factor: 41.582

2.  Bipartite interaction between neurofibromatosis type I protein (neurofibromin) and syndecan transmembrane heparan sulfate proteoglycans.

Authors:  Y P Hsueh; A M Roberts; M Volta; M Sheng; R G Roberts
Journal:  J Neurosci       Date:  2001-06-01       Impact factor: 6.167

Review 3.  Modulation of signalling by Sprouty: a developing story.

Authors:  Hong Joo Kim; Dafna Bar-Sagi
Journal:  Nat Rev Mol Cell Biol       Date:  2004-06       Impact factor: 94.444

4.  Sprouty1 and Sprouty2 provide a control mechanism for the Ras/MAPK signalling pathway.

Authors:  Hiroshi Hanafusa; Satoru Torii; Takayuki Yasunaga; Eisuke Nishida
Journal:  Nat Cell Biol       Date:  2002-11       Impact factor: 28.824

5.  Neurofibromas in NF1: Schwann cell origin and role of tumor environment.

Authors:  Yuan Zhu; Pritam Ghosh; Patrick Charnay; Dennis K Burns; Luis F Parada
Journal:  Science       Date:  2002-05-03       Impact factor: 47.728

6.  Spred is a Sprouty-related suppressor of Ras signalling.

Authors:  T Wakioka; A Sasaki; R Kato; T Shouda; A Matsumoto; K Miyoshi; M Tsuneoka; S Komiya; R Baron; A Yoshimura
Journal:  Nature       Date:  2001-08-09       Impact factor: 49.962

7.  Mammalian Sprouty4 suppresses Ras-independent ERK activation by binding to Raf1.

Authors:  Atsuo Sasaki; Takaharu Taketomi; Reiko Kato; Kazuko Saeki; Atsushi Nonami; Mika Sasaki; Masamitsu Kuriyama; Naoaki Saito; Masabumi Shibuya; Akihiko Yoshimura
Journal:  Nat Cell Biol       Date:  2003-05       Impact factor: 28.824

8.  A shared molecular mechanism underlies the human rasopathies Legius syndrome and Neurofibromatosis-1.

Authors:  Irma B Stowe; Ellen L Mercado; Timothy R Stowe; Erika L Bell; Juan A Oses-Prieto; Hilda Hernández; Alma L Burlingame; Frank McCormick
Journal:  Genes Dev       Date:  2012-07-01       Impact factor: 11.361

9.  Dynamic regulation of the Ras pathway via proteolysis of the NF1 tumor suppressor.

Authors:  Karen Cichowski; Sabrina Santiago; Melanie Jardim; Bryan W Johnson; Tyler Jacks
Journal:  Genes Dev       Date:  2003-02-15       Impact factor: 11.361

10.  Genetic and biochemical evidence that haploinsufficiency of the Nf1 tumor suppressor gene modulates melanocyte and mast cell fates in vivo.

Authors:  D A Ingram; F C Yang; J B Travers; M J Wenning; K Hiatt; S New; A Hood; K Shannon; D A Williams; D W Clapp
Journal:  J Exp Med       Date:  2000-01-03       Impact factor: 14.307

View more
  7 in total

Review 1.  Ras-Specific GTPase-Activating Proteins-Structures, Mechanisms, and Interactions.

Authors:  Klaus Scheffzek; Giridhar Shivalingaiah
Journal:  Cold Spring Harb Perspect Med       Date:  2019-03-01       Impact factor: 6.915

2.  Partial Blindness to Submicron Topography in NF1 Haploinsufficient Cultured Fibroblasts Indicates a New Function of Neurofibromin in Regulation of Mechanosensoric.

Authors:  D Kaufmann; J Hoesch; Y Su; L Deeg; K Mellert; J P Spatz; R Kemkemer
Journal:  Mol Syndromol       Date:  2012-09-27

3.  The neurofibromin recruitment factor Spred1 binds to the GAP related domain without affecting Ras inactivation.

Authors:  Theresia Dunzendorfer-Matt; Ellen L Mercado; Karl Maly; Frank McCormick; Klaus Scheffzek
Journal:  Proc Natl Acad Sci U S A       Date:  2016-06-16       Impact factor: 11.205

4.  Legius Syndrome: two novel mutations in the SPRED1 gene.

Authors:  Marika Bianchi; Veronica Saletti; Roberto Micheli; Silvia Esposito; Anna Molinaro; Stella Gagliardi; Simona Orcesi; Cristina Cereda
Journal:  Hum Genome Var       Date:  2015-12-03

5.  Oncogenic KRAS engages an RSK1/NF1 pathway to inhibit wild-type RAS signaling in pancreatic cancer.

Authors:  Derek K Cheng; Tobiloba E Oni; Jennifer S Thalappillil; Youngkyu Park; Hsiu-Chi Ting; Brinda Alagesan; Nadia V Prasad; Kenneth Addison; Keith D Rivera; Darryl J Pappin; Linda Van Aelst; David A Tuveson
Journal:  Proc Natl Acad Sci U S A       Date:  2021-05-25       Impact factor: 11.205

Review 6.  Negative Regulation of FGFR (Fibroblast Growth Factor Receptor) Signaling.

Authors:  Patrycja Szybowska; Michal Kostas; Jørgen Wesche; Ellen Margrethe Haugsten; Antoni Wiedlocha
Journal:  Cells       Date:  2021-05-28       Impact factor: 6.600

7.  Structural Insights into the SPRED1-Neurofibromin-KRAS Complex and Disruption of SPRED1-Neurofibromin Interaction by Oncogenic EGFR.

Authors:  Wupeng Yan; Evan Markegard; Srisathiyanarayanan Dharmaiah; Anatoly Urisman; Matthew Drew; Dominic Esposito; Klaus Scheffzek; Dwight V Nissley; Frank McCormick; Dhirendra K Simanshu
Journal:  Cell Rep       Date:  2020-07-21       Impact factor: 9.423

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.